Pacific Biosciences of California, Inc. Debt Securities, Available-for-sale
Pacific Biosciences of California, Inc. (PACB) had Debt Securities, Available-for-sale of $561.24 million as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2024-02-28
- 2023-12-31: Debt Securities, Available-for-sale $561.24M.
- 2022-12-31: Debt Securities, Available-for-sale $634.68M.
- 2022-09-30: Debt Securities, Available-for-sale $771.19M.
- 2022-06-30: Debt Securities, Available-for-sale $796.54M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2023-12-31 | $561.24M 10-K · filed 2024-02-28 |
| 2022-12-31 | $634.68M 10-K · filed 2023-02-28 |
| 2022-09-30 | $771.19M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $796.54M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $735.52M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $717.09M 10-K · filed 2022-02-28 |
| 2021-09-30 | $715.87M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $880.94M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $253.87M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $275.77M 10-K · filed 2021-02-26 |
| 2020-09-30 | $166.77M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $86.67M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $110.06M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $30.45M 10-K · filed 2020-02-28 |
| 2019-09-30 | $30.70M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $49.72M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $53.54M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $83.51M 10-K · filed 2019-02-26 |
| 2018-09-30 | $88.36M 10-Q · filed 2018-11-05 |
| 2017-09-30 | $61.68M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $85.44M 10-Q · filed 2017-08-02 |
| 2014-12-31 | $79.40M 10-K · filed 2015-03-12 |
| 2014-09-30 | $82.80M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $93.33M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $98.85M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $99.56M 10-K · filed 2014-03-14 |
| 2013-09-30 | $81.36M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $86.93M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $88.73M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |